NEWSPAPER HEADLINES
Corona related stories continue to dominate front pages of most of the dailies.
"Bharat Biotech cuts Covaxin's price for states after SII move," writes Hindustan Times. "Now, Biotech cuts Covaxin rate by 200 rupees for states." The Tribune headlines, "Most in India support Covid jab certificate for international travel says study."
Times of India says Army opens its hospitals to civilians. The paper also reports that Uttarakhand suspends Char Dham yatra.
In order to contain rising covid cases in UP, The Pioneer headlines, "UP extends weekend curfew till Tuesday morning."
The paper also reports that Ayush-64 useful in treating mild to moderate Covid cases.
Economic Times says, "US directs 20 million doses of its AstraZeneca vaccine to India."
No comments:
Post a Comment